XENIKOS
Xenikos aims to develop a new medicine, based on the action of antibodies that enables patients suffering serious immune diseases, or rejection after transplantation, to reset their immune system quickly and efficiently. Xenikos strives to develop new, innovative immunotherapy medicines to help restore patients’ health and save lives.
XENIKOS
Industry:
Biotechnology Life Science Therapeutics
Founded:
2009-01-01
Address:
Nijmegen, Gelderland, The Netherlands
Country:
The Netherlands
Website Url:
http://www.xenikos.com
Total Employee:
1+
Status:
Active
Contact:
+31 24 300 01 00
Email Addresses:
[email protected]
Total Funding:
84.25 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible WordPress Mobile Non Scaleable Content Sitelinks Search Box Euro Yoast WordPress SEO Plugin Google Maps ReCAPTCHA Yoast SEO Premium
Similar Organizations
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Axcella
Axcella is a biotechnology company providing therapeutics development solutions.
Cognition Therapeutics
Cognition Therapeutics develops new therapeutics to treat patients suffering from Alzheimer’s disease and other neurodegenerative disorders.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Hookipa Pharma
Hookipa is a clinical stage biotech company developing best-in-class active immunization therapies for infectious diseases and oncology.
Scholar Rock
Scholar Rock is a biopharmaceutical company that develops and discovers new medicines and treatments for the serious diseases.
Spero Therapeutics
Spero Therapeutics is developing first in class therapeutics for treatment of gram-negative infections.
Current Advisors List
Current Employees Featured
Founder
Investors List
Sanquin Blood Supply Foundation
Sanquin Blood Supply Foundation investment in Convertible Note - Xenikos
Medicxi
Medicxi investment in Convertible Note - Xenikos
OostNL
OostNL investment in Convertible Note - Xenikos
RA Capital Management
RA Capital Management investment in Convertible Note - Xenikos
Veloxis
Veloxis investment in Convertible Note - Xenikos
Medicxi
Medicxi investment in Series B - Xenikos
RA Capital Management
RA Capital Management investment in Series B - Xenikos
Agentschap NL
Agentschap NL investment in Debt Financing - Xenikos
Innovation & Investment Fund Gelderland
Innovation & Investment Fund Gelderland investment in Series A - Xenikos
Sanquin Blood Supply Foundation
Sanquin Blood Supply Foundation investment in Series A - Xenikos
Key Employee Changes
| Date | New article |
|---|---|
| 2021-09-22 | Xenikos Appoints Hassan Aly, MD, PhD as Chief Medical Officer |
| 2019-12-03 | Xenikos appoints Chief Financial Officer and Chief Business Officer |
Official Site Inspections
http://www.xenikos.com
- Host name: host37-5.registrar-servers.com
- IP address: 185.61.152.55
- Location: United Kingdom
- Latitude: 51.4964
- Longitude: -0.1224
- Timezone: Europe/London
